期刊文献+

p53基因在宫颈癌发病中的意义及对放射敏感性的影响 被引量:9

Significance of p53 in cervical cancer and its influence on radiosensitivity
原文传递
导出
摘要 放疗在宫颈癌治疗中具有重要地位,但放疗抵抗导致局部未控仍常见,因此预测放射敏感性对制定个体化治疗策略是非常有益的.影响放射敏感性的因素有很多,p53状态是重要因素之一,p53基因上下游信号分子的调控亦能影响宫颈癌放射敏感性.本文分析了p53基因在不同宫颈癌中的差异,并探讨p53调控放射敏感性的可能方式. Radiotherapy is a major local treatment for cervical cancer.However, local uncontrollability due to radioresistance is still common.Therefore, the prediction of radiosensitivity is quite beneficial to develop an optimal treatment strategy for individual patients.Multiple factors could influence the radiosensitivity of cells, and p53 status is one of them.The upstream or downstream molecules of p53 could also be regulated to affect the radiosensitivity of cervical cancer.The aim of the review is to analyze the difference in p53 status between different types of cervical cancer and to discuss how p53 regulates the response to radiotherapy.
作者 李平 陈敏斌
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2017年第5期593-597,共5页 Chinese Journal of Radiation Oncology
基金 国家自然科学面上基金(81472786) 昆山市宫颈癌综合诊疗的全程管理(LCZX201619)
关键词 P53基因 宫颈癌 放射敏感性 调控 p53 gene Cervical neoplasms Radiosensitivity Regulate
  • 相关文献

参考文献3

二级参考文献26

  • 1Sandur SK, Deorukhkar A, Pandey MK, et al. Curcumin modulates the radiosensitivity of colorectal cancer ceils by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys, 2009,75(2):534-542.
  • 2Komuro Y, Watanabe T, Tsurita G, et al. Expression pattern of telomerase reverse transcriptase in recta| carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival. Hepatogastroenterology, 2005,52(64) :985-989.
  • 3Wu XY, Xu Z, Chen C, et al. Growth hormone receptor overexpression predicts response of rectal cancers to preoperative radiotherapy. Eur J Cancer, 2006,42(7):888-894.
  • 4Schwartz JL, Rasey J, Wiens L,et al. Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage. Int J Radiat, 1999,75(3) :285 -291.
  • 5Chin KV, Ueda K, Pastanl I, et al. Modulation of active of the promoter of the human MDR1 gene by Ras and p53. Science, 1992,255(5043):459-462.
  • 6Russel FG, Koenderink JB, Masereeuw R. Muhidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends in Pharmacol Sci, 2008,29(4) : 200-207.
  • 7Gradilone A, Puleinelli FM, Lotti LV, et al. Celecoxib upregulates muhidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr Cancer Drug Targets, 2008,8(5) :414-420.
  • 8Stammler G, Pommerenke EW, Mattern J, et al. Effects of single doses of irradiation of on the expression of resistance- related proteins in murine NIH 3T3 and human lung carcinoma cells. Carcinogenesis, 1995,16(9) :2051-2055.
  • 9Hammond CL, Marchan R, Krance SM. Glutathione export during apoptosis requires functional multidrug resistance associated proteins. J Biol Chem, 2007,282(19):14337-14347.
  • 10Colorectal Cancer Collaborative Group.Adjuvant radiotherapy for rectal cancer: a systematic overvi-ew of 8507 patients from 22 randomised trials. Lancet, 2001,358 (9290) : 1291- 1304.

共引文献26

同被引文献102

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部